Related Experiment Video
Updated: Sep 9, 2025

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
Published on: November 11, 2021
Aliança AMARTE: A Collaborative Network to Improve Oncologic Pediatric Care in Brazil
Luiz Fernando Lopes1,2, Patrícia Loggetto2, André de Oliveira Junior1
1Hospital De Câncer Infantojuvenil De Barretos, Barretos, São Paulo, Brazil.
The AMARTE Alliance improved pediatric cancer care in Brazil through collaboration. This network enhanced diagnostics, treatment, and research, despite challenges in sustainable participation and governance.
Area of Science:
- Pediatric Oncology
- Health Equity
- Collaborative Networks
Background:
- Significant regional disparities in childhood cancer treatment access and survival exist in Brazil.
- Initiated in 2014 with six hospitals, the AMARTE Alliance expanded to 31 institutions by 2024.
- The alliance aims to enhance pediatric oncology care quality nationwide.
Purpose of the Study:
- To establish a collaborative network for pediatric oncology care in Brazil.
- To address inequalities in diagnostics and treatment across geographic regions.
- To foster innovation, research, and specialized training in pediatric cancer care.
Main Methods:
- The AMARTE Alliance operates on four pillars: equalizing diagnostics, standardizing treatment, conducting survival studies, and promoting scientific development.
- Infrastructure and human resources are supported by Fundação Pio XII and St. Jude Children's Research Hospital.
- A semestral assessment (SCORE) monitors member progress and engagement using defined indicators.
Main Results:
- Three engagement reports show progress, with 17 hospitals improving their SCORE.
- Key achievements include a shared data registry, standardized protocols, regular scientific meetings, and a dedicated fundraising group.
- The alliance has fostered a collaborative environment for innovation and learning.
Conclusions:
- The AMARTE Alliance demonstrates the critical role of collaboration in advancing pediatric oncology.
- Challenges remain in ensuring sustained specialist participation and navigating diverse governance structures.
- Developing outcome indicators is crucial for evaluating the long-term impact of the alliance.
More Related Videos
11:18Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
Published on: January 22, 2011
07:39Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
Published on: November 17, 2021
Related Concept Videos
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Tumor Immunotherapy
Chronic Kidney Disease III: Interprofessional Care